Carving a Path Toward Pragmatic Innovation in Clinical Trials

A pattern quickly emerged after speaking to clinical data executives at events in Basel, New York, London, and Copenhagen. Although thousands of miles apart, the focus on simplifying and standardizing data was clear. This common thread is a result of increasing complexity in the clinical landscape and more companies are adopting pragmatic innovation to streamline study execution.

The FDA recently issued guidance that encourages practical clinical trials for specific situations. By adding design elements into a study similar to routine clinical practice, more patients (including those from diverse populations) can gain access to participate, enroll, and contribute to clinical research.

Insights from clinical leaders helped surface five trends in the move to pragmatic innovation that will